Biblio Discovery — Demo Discovery Service

8 results for "Sheri Booten"

Showing 1–8 · 1.99 seconds · RSS

  1. Journal Article

    Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice

    Hichem Tasfaout; Suzie Buono; Shuling Guo et al.

    Nature Communications, Vol. 8 No. 1 · 2017 · English · DOAJ Scopus

    X-linked myotubular myopathy is caused by mutations in the gene coding for myotubularin 1, and is characterized by overexpression of dynamin 2. Here the authors develop antisense oligonucleotides to dynamin 2, and show that systemic injection leads to improved pathology in mice.

  2. Journal Article

    Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein

    Richard G. Lee; Wuxia Fu; Mark J. Graham et al.

    Journal of Lipid Research, Vol. 54 No. 3 · 2013 · English · DOAJ Scopus

    Therapeutic agents that suppress apolipoprotein B (apoB) and microsomal triglyceride transfer protein (MTP) levels/activity are being developed in the clinic to benefit patients who are unable to reach target LDL-C levels with maximally tolerated lipid-lowering drugs. To compare and contrast the…

  3. Journal Article Full text

    Partial Hepatectomy Induced Long Noncoding RNA Inhibits Hepatocyte Proliferation during Liver Regeneration

    Lulu Huang; Sagar S. Damle; Sheri Booten et al.

    PLOS ONE, Vol. 10 No. 7 · 2015 · English · PLOS Scopus

    Liver regeneration after partial hepatectomy (PHx) is a complex and well-orchestrated biological process in which synchronized cell proliferation is induced in response to the loss of liver mass. To define long noncoding RNAs (lncRNAs) that participate in the regulation of liver regeneration, we…

    Also available at: DOAJ

  4. Journal Article

    Targeting STE20-type kinase MST3 improves metabolic dysfunction-associated steatohepatitis without affecting hepatocellular carcinoma development in mice

    Jingjing Zhang; Xiangdong Gongye; Lohitesh Kovooru et al.

    BMC Medicine, Vol. 24 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Metabolic dysfunction-associated steatohepatitis (MASH) is a major precursor of hepatocellular carcinoma (HCC), yet the molecular mechanisms linking steatohepatitis to malignancy remain poorly defined. The STE20-type kinase MST3 associates with hepatocellular lipid droplets and…

  5. Journal Article

    Inhibition of GCKIII kinases STK25 and MST3 mitigates organ lipotoxicity and enhances metabolic resilience under nutritional stress

    Emma Andersson; Xiangdong Gongye; Emmelie Cansby et al.

    BMC Medicine, Vol. 23 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Obesity has reached pandemic proportions, highlighting the urgent need for continued research to uncover the molecular mechanisms governing lipid homeostasis and ectopic fat deposition in overnutrition. Our recent translational studies demonstrated that STE20-type kinases STK25…

  6. Journal Article

    Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data

    Nicholas J. Viney; Shuling Guo; Li‐Jung Tai et al.

    ESC Heart Failure, Vol. 8 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Aims Amyloidogenic transthyretin (ATTR) amyloidosis is a fatal disease characterized by progressive cardiomyopathy and/or polyneuropathy. AKCEA‐TTR‐LRx (ION‐682884) is a ligand‐conjugated antisense drug designed for receptor‐mediated uptake by hepatocytes, the primary source of circulating…

  7. Journal Article

    Therapeutic Potential of STE20-Type Kinase STK25 Inhibition for the Prevention and Treatment of Metabolically Induced Hepatocellular CarcinomaSummary

    Ying Xia; Mara Caputo; Emma Andersson et al.

    Cellular and Molecular Gastroenterology and Hepatology, Vol. 19 No. 7 · 2025 · English · DOAJ Scopus

    Background & Aims: Hepatocellular carcinoma (HCC) is a rapidly growing malignancy with high mortality. Recently, metabolic dysfunction-associated steatohepatitis (MASH) has emerged as a major HCC catalyst; however, signals driving transition of MASH to HCC remain elusive and treatment options are…